Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis

Rheumatology key messageInitial treat-to-target therapy in early rheumatoid arthritis has sustained cardiovascular risk benefits at 4 years.
Source: Rheumatology - Category: Rheumatology Source Type: research